Skip to main content
. 2017 Mar 7;8(15):25433–25441. doi: 10.18632/oncotarget.15989

Figure 2.

Figure 2

Kaplan-Meier curves of disease-free (A and B) and progression-free survival (C and D) according to HER-2 status (Panel A and C = HER-2 negative; Panel B and D = HER-2 positive).